Product Information
BUSPIRONE HCL 30 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.1187 per EA under NDC 68382018305. Its NADAC has been published 619 times since Oct 15, 2014.
FDA first approved this application on Feb 7, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382018305
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
BUSPIRONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078888FDA Approved
2/7/2014
TE Code
AB
On Market Since
5/3/2014
Price Statistics
The NADAC for BUSPIRONE HCL 30 MG TABLET has been published 619 times since Oct 15, 2014, and over the history we have for it it has declined 80.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1187 per EA |
|---|---|
| All-time high | $0.6238 (Mar 11, 2015) |
| All-time low | $0.0971 (May 22, 2024) |
| 52-week high | $0.1235 |
| 52-week low | $0.1098 |
| Median price | $0.2495 |
| Average price | $0.2858 |
| Largest weekly change | +36.0% (Jun 19, 2024) |
| Weeks tracked | 619 |
| Tracking since | Oct 15, 2014 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUSPIRONE HCL 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 30 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.1187 per EA (NDC 68382018305), effective Aug 19, 2026.
How has the price of BUSPIRONE HCL 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUSPIRONE HCL 30 MG TABLET has declined 80.1%. It has been tracked across 619 weekly CMS publications since Oct 15, 2014.
What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 30 MG TABLET?
Since Oct 15, 2014, the NADAC for BUSPIRONE HCL 30 MG TABLET has ranged from a low of $0.0971 (May 22, 2024) to a high of $0.6238 (Mar 11, 2015), with a median of $0.2495 per EA.
Are there cheaper alternatives to BUSPIRONE HCL 30 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUSPIRONE HCL 30 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures BUSPIRONE HCL 30 MG TABLET?
BUSPIRONE HCL 30 MG TABLET (NDC 68382018305) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.